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Pleural Effusion in Michigan Caused by Coccidioides Immitis After
Ttavel to an Endemic Area
Christopher W. Hughes, MD,* and Paul A. Kvale, MD*

Primary coccidioidal disease is rarely diagnosed in the midwest in the nonimmunocompromised host.
Since coast-to-coast travel is common today, many patients may become exposed to Coccidioides
immitis while traveling in endemic areas. We present a case of acute coccidioidal pleural effusion in a
Michigan woman who had recently visited northeastern Arizona. Her travel history was the single
most important factor in the eventual diagnosis of coccidioidal pleural effusion. (Henry Ford Hosp
MedJ 1989;37:47-9)

C

occidioidomycosis is an endemic disease in the southwestem United States, but may be seen in nonendemic locations due to patients' travels. Pleural effusions caused by Coccidioides immitis occur in about 7% of adult patients during the
primary infection; the effusions are generally "benign" and require no specific therapy (1). Coccidioidomycosis should be
considered in the differential diagnosis of pleural effusion occurring in patients with the proper clinical manifestations and a
history of travel to an endemic area.

Case Report
This previously healthy 47-year-old white female was initially evaluated by her private physician because of left-sided pleuritic chest pain
after retuming home to Michigan from Arizona. (She hadti-avelednumerous times to Arizona during the preceding six months.) Her clinical
examination, electrocardiogram, and chest roentgenogram (Fig 1) were
normal. Two months later the pleuritic chest pain had largely abated,
but she complained of a pulling and catching in her left hemithorax with
deep inspiration, associated with general malaise and temperature
spikes of > 38.3°C (lOrF). She denied cough, dyspnea, wheezing,
anorexia, chills, night sweats, or skin rashes. She did not smoke, drank
alcohol socially, and had no significant medical history. There was no
known exposure to asbestos. She had no unusual hobbies or habits. She
took no medicines and had no allergies. Physical examination revealed
an anxious female in no acute distress. Her temperature was 38.TC
(100.6°F), blood pressure 130/70 mm Hg, heart rate 80 beats/min, and
respiration 14 breaths/min and unlabored. The left lower hemithorax
was dull to percussion with decreased breath sounds. The remainder of
her physical examination was normal; specifically, she had no skin rash.
Chest roentgenogram revealed a moderate, left-sided pleural effusion
without lymphadenopathy. Computed tomography (CT) studies of the
abdomen and thorax were normal except for the pleural effusion; specifically, there was no hilar or mediastinal lymphadenopathy. There was
no reaction to PPD and a positive reaction to mumps and Candida control skin tests. Complete blood count revealed a hemoglobin of 141 g/L
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(14.1 g/dL), WBC count of 8.7 x lO'/L (8,700/fjiL) with 0.07 (7%)
eosinophils on differential. SMAC results were normal. ANA and
rheumatoid factor were negative. Thoracentesis revealed straw-colored
fluid, protein 53 g/L (5.3 g/dL), lactic dehydrogenase 331 U/L, WBC
count 4.2 X lO'/L (4,160/|xL) with 0.72 (72%) lymphocytes, 0.18
(18%) monocytes, 0.09 (9%) eosinophils, 0.01 (1%) basophils, 0.15
(15%) nonhematologic cells, and RBC count 860 x W/L (860/(JLL).
Cytology of the pleural fluid was negative for malignancy. Pleural biopsy showed noncaseating granulomata. Routine gram stain, culture
and sensitivity, fungal stain, and acid-fast bacillus (AFB) stain were
negative for both pleural fluid and biopsies. Fungal and AFB cultures
were negative. Bronchoscopy and transbronchial biopsy were nonspecific, and neither AFB nor fungi were recovered. The patient was
placed on 300 mg/day of isonicotinoylhydrazine (INH), 600 mg/day of
rifampin, and aspirin as needed and was sent to Henry Ford Hospital for
consultation.
At our initial evaluation the patient's complaints had largely resolved . She no longer had fever and her chest discomfort had improved,
but she still felt fatigued. On physical examination temperature was
37°C (98.6°F), blood pressure 130/70 mm Hg, heart rate 80 beats/min,
and respiration 16 breaths/min and unlabored. Again, the only significant physicalfindingswere dullness to percussion and decreased breath
sounds in the left lower hemithorax. Chest roentgenogram revealed a
left pleural effusion (Fig 2). CT of the thorax revealed no additional abnormalities. A repeat PPD was negative with positive control skin tests.
The coccidioidal immunodiffusion titers were positive at 1:16 with full
identity of all bands; complement fixation titers were also positive at
1:8. Immunodiffusion titers and complement fixation titers for A^pergillus, blastomycosis, and histoplasmosis were negative. Repeat
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Fig 1—Baseline chest x-ray from two years prior to acute illness. There was no change in the x-ray obtained on first
presentation.

Fig 2—Chest x-ray two months after initial presentation revealing moderate left pleural effusion.

fungal and AFB cultures of the pleural fluid and pleural biopsies revealed no growth. INH andrifampinwere discontinued, and the patient
continued to improve both clinically and by chest roentgenogram (Fig
3). On the advice of a third consultant elsewhere she was placed on 400
mg/day of ketoconazole for the last several months of her course.

patient denied any form of skin rash, which may have given
other physicians a better clue to the correct diagnosis earlier.
Erythema multiforme and toxic erythema (a diffuse maculopapular emption) are additional dermatologic manifestations
commonly seen with primary coccidioidal pulmonary infections. Typical "valley fever" consists of erythema nodosum or
erythema multiforme plus arthralgias or arthritis and sometimes
mild conjunctivitis.
Most patients with primary coccidioidomycosis have abnormal
chest roentgenograms. Alveolar infiltrates are the most common,
usually seen in one segment or lobe, extending to the visceral
pleura in all cases (1). Atelectasis is also common. Hilar adenopathy is seen in 20% of cases, usually ipsilateral to the infiltrate.
Again, these clues to the diagnosis were lacking in our patient, perhaps because of die fortuitous timing when chest roentgenograms
were obtained. Although small pleural effusions may be seen in
20% of patients, larger pleural effusions are seen in only 2% to 6%
of patients (3). The effusions are unilateral and represent a parapneumonic process rather than an extrathoracic dissemination.
Davies (2) states that sterile pleural effusions and pleurisy occur in
5% to 10% of cases and likely represent hypersensitivity rather than
infection. Pleural effusions may also occur in the chronic form of
coccidioidomycosis, but often represent empyema with or without
bronchopleural fistula contributing to an increased acute and
chronic morbidity (4).
Serologic studies are extremely important in establishing a
definitive diagnosis, particularly in the absence of recovery of

Discussion
Coccidioidomycosis is caused by a tissue dimorphic soil
fungus endemic in the desert of southwestem United States, particularly the San loaquin Valley of Califomia, Arizona, and
New Mexico (2). Approximately 50,000 persons are infected
each year, and in susceptible populations about 0.4% per year
seek medical help for their infections (3). Less than half of the
patients with primary pulmonary coccidioidomycosis are symptomatic. The most common manifestation is a febrile pulmonary
illness much like influenza. The most common symptoms associated with primary pulmonary infection are cough, fever, and
chest pain, seen in 70% to 90% of patients (3). Cough is usually
associated with small amounts of sputum which may be streaked
with blood. Night sweats may accompany the fever. The chest
pain (82% of patients) is usually pleuritic. Fatigue and lethargy
may be profound. Other, less common symptoms seen with the
primary infection are headache, sore throat, diffuse muscle
aches, and loss of appetite (3).
Over one-third of the patients have peripheral eosinophilia
and one-half have erythema nodosum or erythema multiforme
(4). Erythema nodosum is especially common in women. Our
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the organism on cultures or stains of body fluids or tissues. The
coccidioidin skin test is usually positive and serum complement
fixation titers are elevated ( > 1:16) (4). In our patient the immunodiffusion test was positive with fufi identity to all coccidioidin
bands at a titer of 1:16 during the time she presented to us. Follow-up serology was not possible since she chose to go elsewhere for continuing care. The immunodiffusion test we employed largely measures IgG precipitating antibodies, with the
patient's semm being matched with a known positive control to
Coccidioides immitis. The antigen is an "F" antigen, which is a
mycelialfiltrateand predominantly measures IgG antibody. The
serum was sent to the Michigan Department of Public Health,
where a complement fixation test was also positive at a titer of
1:8. This is significant because the complement fixation test essentially uses the same antigen that we use (the "F" antigen) in
the immunodiffusion test. The complement fixation test is more
sensitive, but less specific. Our patient's semm was negative for
Aspergillus, blastomycosis, and histoplasmosis on immunodiffusion testing, and negative to blastomycosis and histoplasmosis at the Michigan Department of Public Health for complement fixation antibodies. There is much less cross-reactivity
with the immunodiffusion test since we can monitor the bands of
identity. With full identity, such as was demonstrated in our laboratory, we can confidently conclude that the patient had a
positive serologic test for coccidioidomycosis. "TP" antibody
(an IgM antibody) was not tested in our laboratory.
Fig 3—Follow-up chest x-ray showing resolution of left pleural
The pleural fluid findings in our patient were those of any noneffusion.
specific granulomatous pleuritis. Although Coccidioides immitis is often recovered from pleural biopsy (and less frequently
amphotericin B should be employed. The utility of kefrom pleural fluid), we were unable to recover these organisms
toconazole in the setting of a pleural effusion accompanying prifrom our patient. However, the serologic studies discussed allow
mary pulmonary coccidioidomycosis has not yet been
for a confident diagnosis of the pleural effusion caused by infecdetermined.
tion with Coccidioides immitis.
The course of primary pulmonary coccidioidomycosis is typAcknowledgments
ically benign, and symptoms resolve without specific therapy
We thank Charisse Lukaszek and Patti LaFollette for their
unless dissemination or relapse occurs. Even when pleural effu- assistance in the preparation of this manuscript.
sions accompany the primary infection, treatment is rarely necessary; fluid resolution is slow, often taking one to eight weeks
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